PerkinElmer Introduces First Ready-to-use HTRF® and AlphaLISA® Assay Kits for CHO HCP Impurities Detection and Quantification

New high-throughput, no-wash assays contribute to the development, manufacture and quality control of safer, more effective biotherapeutics WALTHAM, Mass.–(BUSINESS WIRE)–Apr. 4, 2022– PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced two ready-to-use HTRF® and AlphaLISA® no-wash assay kits designed to quickly and easily detect and quantify CHO HCP impurities during... Read more

Canopy Biosciences Launches Next-Generation ChipCytometry™ Instrument for Spatial Biology with Sub-Cellular Resolution

New CellScape™ System Provides Exceptional Quantitative Performance for High-Plex and High-Throughput Targeted Spatial Proteomics ST. LOUIS–(BUSINESS WIRE)– Canopy Biosciences, a Bruker Company, today announced the commercial launch of the CellScapeTM system, the next generation in ChipCytometryTM instrumentation, advancing the cutting-edge for quantitative in situ spatial phenotyping. ChipCytometry delivers single-cell targeted spatial proteomics for complex whole-tissue... Read more

PacBio Announces Fourth Quarter and Fiscal Year 2021 Financial Results

MENLO PARK, Calif., Feb. 15, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2021. Updates since our last earnings release Achieved record fourth quarter revenues of $36.0 million reflecting growth of 33% compared to the prior year period and grew the Sequel II/IIe... Read more

Bruker Enables High-Throughput Multiplex HTS on Sierra SPR Platform

Sierra Surface Plasmon Resonance (SPR) Pro Series for High-Throughput Screening (HTS) Innovative Sierra SPR-32 Pro allowing multiplex HTS for insights into kinetics with no compromise in sensitivity and nature of samples SPR insights into molecular interactions by label-free HTS in support of drug discovery BOSTON–(BUSINESS WIRE)– At the SLAS2022 International Conference and Exhibition, Bruker Corporation... Read more

PerkinElmer to Showcase Expanded Life Science / Cell & Gene Therapy Portfolios and Automated Genomic Workflows at SLAS 2022

End-to-end solutions designed to help scientists streamline and improvedrug discovery R&D productivity WHAT:  PerkinElmer, Inc., a global leader committed to innovating for a healthier world, is at SLAS 2022 on February 7-9 along with several of its new partner companies showcasing how its end-to-end life science solutions and automated workflows can accelerate scientists’ R&D productivity... Read more

U.S. Centers for Disease Control Guidance Includes EUROIMMUN Assay in its Two-Step Testing Algorithm for Dengue Virus

EUROIMMUN assay used to detect previous dengue virus infection will help children and adolescents gain access to vaccine WALTHAM, Mass.–(BUSINESS WIRE)–Feb. 3, 2022– EUROIMMUN, a PerkinElmer, Inc. (NYSE:PKI) company, today announced that its EUROIMMUN® Anti-Dengue Virus NS1 Type 1-4 ELISA (IgG) (research use only) was cited by the U.S. Centers for Disease Control and Prevention... Read more

BD REPORTS FIRST QUARTER FISCAL 2022 FINANCIAL RESULTS

FRANKLIN LAKES, N.J., Feb. 3, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its first quarter of fiscal year 2022, which ended December 31, 2021. “Our first quarter results reflect continued execution of our BD2025 strategy and strong base business performance from all three segments.... Read more

Azenta Life Sciences Names Matthew McManus Chief Operating Officer

CHELMSFORD, Mass., Jan. 6, 2022 /PRNewswire/ — Azenta, Inc. (Nasdaq: AZTA) today announced that it has appointed Matthew McManus Chief Operating Officer effective January 17th.  In this newly created role, Dr. McManus will oversee Life Sciences Products, Services, and all commercial operations of the business and will report directly to the CEO. “We are excited to have Matt join the Company... Read more

Roche launches the AVENIO Edge System to simplify and automate next-generation sequencing sample preparation, reduce human error and advance precision medicine

Next-generation sequencing (NGS) enables a better understanding of genetic mechanisms linked to specific diseases and is helping drive personalised healthcare Preparing DNA for sequencing libraries is complex and prone to human error, which can interfere with accurate sequencing results The new AVENIO Edge System is a fully-automated solution for the sample preparation workflow, from DNA... Read more

3D Printing of Nanoporous Polymers

3D printing offers great flexibility in the creation of precisely engineered objects with highly complex geometries. This is rapidly opening up possibilities in many fields, including aerospace, robotics, construction and medicine. External content Nature Communications: 3D printing of inherently nanoporous polymers via polymerization-induced phase separation 3D printing offers enormous flexibility in fabrication of polymer objects... Read more